Hitomi Mori

The combination of PD-L1 expression and decreased tumor-infiltrating lymphocytes is associated with a poor prognosis in triple-negative breast cancer

Hitomi Mori, Makoto Kubo, Rin Yamaguchi et al. · Oncotarget · 2017 · 125 citations · Full text

Medicine, Immunology, Oncology +17

Comprehensive molecular profiling broadens treatment options for breast cancer patients

Hitomi Kawaji, Makoto Kubo, Nami Yamashita et al. · Cancer Medicine · 2020 · 37 citations · Full text

Medicine, Molecular Genetics, Oncology +17

White button mushroom (Agaricus bisporus) disrupts androgen receptor signaling in human prostate cancer cells and patient-derived xenograft

Xiaoqiang Wang, Desiree Ha, Hitomi Mori et al. · The Journal of Nutritional Biochemistry · 2020 · 35 citations · Full text

Medicine, Cancer Biology, Oncology +17

Catumaxomab with Activated T-cells Efficiently Lyses Chemoresistant EpCAM-positive Triple-negative Breast Cancer Cell Lines

Makoto Kubo, Masayo Umebayashi, Kanako Kurata et al. · Anticancer Research · 2018 · 34 citations · Full text

Medicine, Cancer Biology, Oncology +17

T-bet+ lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer

Hitomi Mori, Makoto Kubo, Masaya Kai et al. · Breast Cancer Research and Treatment · 2019 · 30 citations · Full text

Life Sciences, Immunology, Oncology +17